Pathfinders in Biopharma
En podcast av RBC Capital Markets
46 Avsnitt
-
ECM: Robust End to Year, Despite Previous Volatility
Publicerades: 2023-10-31 -
Biotech Halftime Report: A Winding Road Ahead
Publicerades: 2023-09-26 -
The Urgent Need to Address the Youth Mental Health Landscape
Publicerades: 2023-08-17 -
Website Traffic Reveals Biopharma Sales Trends
Publicerades: 2023-08-07 -
When to Call it Quits: VCs Making Tough Decisions in a Tough Market
Publicerades: 2023-07-13 -
How Biotech M&A is Redefining the Strategic Landscape
Publicerades: 2023-06-23 -
Healthcare Should Get Ready for ‘Fast and Furious’ M&A
Publicerades: 2023-06-08 -
Innovation and Growth: Key Ingredients to Healthcare M&A
Publicerades: 2023-06-07 -
Biotech M&A Booms, But Have Buyouts Reached a Tipping Point?
Publicerades: 2023-06-02 -
Global Blood Therapeutics Commitment to Sickle-Cell Innovation
Publicerades: 2023-05-22 -
Is This the Breakthrough Moment for Genetic Medicine?
Publicerades: 2023-04-13 -
The Hidden Revolution Set to Turn US Healthcare on its Head
Publicerades: 2023-01-26 -
The Big Picture for Biotech
Publicerades: 2022-12-13 -
Why Biopharma Investment Requires a Different Mindset
Publicerades: 2022-11-22 -
The Optimism Behind the Biopharma Market
Publicerades: 2022-10-03 -
Biotech Investors: How to Find Value in a Bear Market
Publicerades: 2022-03-21 -
A call to action: Global Blood Therapeutics on tackling orphan disease
Publicerades: 2021-12-08 -
Ionis: Raising The Bar For ESG
Publicerades: 2021-10-28 -
Biotech and Big Pharma: Blueprint for Successful Partnership
Publicerades: 2021-09-30 -
What’s Material in ESG for Biopharma Firms?
Publicerades: 2021-05-04
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
